Regulatory Open Forum

 View Only
  • 1.  Trunk Stock - managing MDR requirements

    This message was posted by a user wishing to remain anonymous
    Posted 03-May-2021 15:02
    This message was posted by a user wishing to remain anonymous

    Hoping for some feedback from this community regarding field specialists maintaining their own "trunk stock" and how this can be managed under MDR, especially considering the enhanced traceability requirements. 

    If a field specialist (manufacturer employee) is taking stock directly from the importer and transporting it to healthcare facilities, what are they considered in the supply chain? And is it sufficient for the importer to track the inventory they have passed to the FS, then for the FS to track which inventory they have delivered to/used at which facilities? 

    Can anyone offer some best practices or pointers for best managing this scenario? We had hoped to discontinue the use of trunk stock under MDR, but our marketing team has made it clear this is a no-go from their perspective. 


  • 2.  RE: Trunk Stock - managing MDR requirements

    Posted 04-May-2021 08:50
    Hello Anonymous,
    In my opinion, the role of the FS is that of the organisation they belong to. The importer has put the product through customs and placed it on the EU market (by definition of importer). If the FS belong to the same organisation of the importer, then the importer is a distributor as well. If the FS belong to a different organisation (e.g. the country affiliate) then their role is that of a distributor. The organisation should have procedure in place to address requirements applicable to their role. The FS will act according to these procedures. The traceability requirements are specified in Article 25: The importer/distributor will need to be able to identify economic operators from whom they have received a device, and economic operators and health care facilities to whom they have supplied a device.  I do not see any special or different requirement applicable to trunk stock as opposed to devices held at the distributor's.

    ------------------------------
    Andrea Sparti
    Head of Regulatory Affairs
    Ypsomed AG
    Burgdorf
    Switzerland
    ------------------------------